Lucy Scientific Discovery Statistics
Total Valuation
Lucy Scientific Discovery has a market cap or net worth of 882. The enterprise value is -140,698.
| Market Cap | 882 |
| Enterprise Value | -140,698 |
Important Dates
The next estimated earnings date is Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Lucy Scientific Discovery has 1.76 million shares outstanding. The number of shares has increased by 56.90% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.76M |
| Shares Change (YoY) | +56.90% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 16.52% |
| Owned by Institutions (%) | 7.90% |
| Float | 1.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.05 |
| PB Ratio | 0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.01 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.38, with a Debt / Equity ratio of 0.86.
| Current Ratio | 0.38 |
| Quick Ratio | 0.06 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -99.35% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 8,366 |
| Profits Per Employee | -5.65M |
| Employee Count | 2 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.96% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -99.96% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.81 |
| Relative Strength Index (RSI) | 44.72 |
| Average Volume (20 Days) | 3,898 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.61 |
Income Statement
In the last 12 months, Lucy Scientific Discovery had revenue of 16,732 and -11.30 million in losses. Loss per share was -6.94.
| Revenue | 16,732 |
| Gross Profit | 8,364 |
| Operating Income | -7.20M |
| Pretax Income | -10.23M |
| Net Income | -11.30M |
| EBITDA | n/a |
| EBIT | -7.20M |
| Loss Per Share | -6.94 |
Balance Sheet
The company has 211,120 in cash and 69,543 in debt, giving a net cash position of 141,577 or 0.08 per share.
| Cash & Cash Equivalents | 211,120 |
| Total Debt | 69,543 |
| Net Cash | 141,577 |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 81,158 |
| Book Value Per Share | 0.05 |
| Working Capital | -2.15M |
Cash Flow
| Operating Cash Flow | -5.92M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 49.99% |
| Operating Margin | -43,053.07% |
| Pretax Margin | -61,141.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Lucy Scientific Discovery does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -56.90% |
| Shareholder Yield | -56.90% |
| Earnings Yield | -1,387,735.60% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on February 26, 2024. It was a reverse split with a ratio of 0.1.
| Last Split Date | Feb 26, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
Lucy Scientific Discovery has an Altman Z-Score of -19.92. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.92 |
| Piotroski F-Score | n/a |